Amy C. Moore, PhD
@acmoorephd.bsky.social
Internationally-recognized KOL and patient advocate. Director, Patient Engagement & Advocacy at Summit Therapeutics. Views = my own
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy @acmoorephd.bsky.social oncodaily.com/blog/255749 #Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy - OncoDaily
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy / Amy C. Moore, cancer, ivonescimab, Lung cancer, OncoDaily,
oncodaily.com
Digging around in the basement and found this old award from AACR broken. But I glued it back together. Because science may be down right now, but it’s not out. We will put the pieces back together.
Here is the pre-RFK vaccination schedule for your kids. Please download it before he is confirmed and changes/deletes it. Give it to your pediatrician and say this is the schedule you want your kids on. Making this my pinned post.
I am proud to have worked with LUNGevity’s partners to develop these #lungcancer resources for members of the AANHPI community lungevity.org/health-equity #LCSM
As February begins, we embrace a month dedicated to recognizing the extraordinary achievements of Black individuals who have shaped our world. Their stories inspire us to rise, challenge the status quo, and create a future filled with hope and progress.
I’m an NSF panel reviewer that was scheduled to meet today. Just got notice that all NSF panels were canceled today. I reviewed some innovative proposals in support of students. Devastating if these scholars don’t get to do this work. For the love of science & students I hope this is just a delay.💔
Having landed my first job outside my postdoc through a cold email, I know the power of that communication and how it can open doors www.nature.com/articles/d41...
Four tips for writing the perfect ‘cold e-mail’ in job applications
These strategies can transform your unsolicited applications from forgettable to fabulous.
nature.com
As a scientist and an advocate, I am grateful for LUNGevity's commitment to continue to work on behalf of ALL people at risk for and impacted by #lungcancer as well as the researchers working to find new treatments. #LCSM
LUNGevity Foundation@lungevity.bsky.social · 2y agoLUNGevity is unwavering in our commitment to funding high-quality lung cancer research, supporting patients and their families, and advocating for health equity, increased awareness, early detection, and improved treatments for lung cancer.
www.statnews.com/2025/01/25/t...
Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?
Have you been affected by the Trump administration’s pause on communications, science meetings, and reviews? @statnews would like to hear from you.
statnews.com
The good news is my ping pong game has really improved this week. Burning off some steam!
a cat is sitting on a ping pong table looking at a blue balloon .
ALT: a cat is sitting on a ping pong table looking at a blue balloon .
media.tenor.com
As a cancer patient community, we are lost for words. Science and research is what keeps us all going. As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.” nature.com/articles/d4158… #LCSM
nature.com
Esther Choo@choo.bsky.social · 2y agoMy NIH study section that was to meet tomorrow was one of those canceled. This represents many months of work by the applicants and by the NIH staff and reviewers. Devastating is the correct word.
A good distraction from a cat-astrophic week for science
Efforts to support clinical trial diversity now at risk www.statnews.com/2025/01/23/f...
FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.
statnews.com
One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer www.biorxiv.org/content/10.1...
Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer
PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease invo...
biorxiv.org
"Any prolonged pause of the #NIH’s study sections could result in funding delays for scientific labs awaiting approval of their work." #CanSky #MedSky #IDSky www.statnews.com/2025/01/22/t...
Trump administration’s abrupt cancellation of scientific meetings prompts confusion, concern
A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the
statnews.com
www.reuters.com/world/us/tru...
Trump officials ask US health agencies to pause external communications, Washington Post reports
The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts, the Washington Post reported on Tuesday, citing a dozen current and former officials and sources.
reuters.com
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC #lcsm #oncology www.onclive.com/view/first-l...
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC
The European Commission approved first-line amivantamab plus lazertinib for EGFR-mutated advanced non–small cell lung cancer.
onclive.com
9.5% MET and 7.9% EGFR detected in pts w lung SqCC with no smoking history. Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease. #lcsm
Amy C. Moore, PhD@acmoorephd.bsky.social · 2y agoBiomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer www.sciencedirect.com/science/arti...
We still have a long way to go to ensure that ALL patients benefit from recent scientific advances in #lungcancer. This study found that overall survival increased by 71% in patients with private insurance compared to only 24% in the uninsured in the US. #LCSM www.jtocrr.org/article/S266...
Recent Survival Gains in Stage IV Non-Small Cell Lung Cancer by Sociodemographic Strata
The management of stage IV non-small cell lung cancer (NSCLC) has been transformed by recent innovations. However, access to medical innovations can be variable across sociodemographic groups in the U...
jtocrr.org
Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer www.sciencedirect.com/science/arti...
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
Next-generation sequencing (NGS) to detect actionable genomic driver alterations (AGAs) is critical to appropriate management of non-small cell lung c…
sciencedirect.com
Excellent review of lung neuroendocrine neoplasms by Dr Sen, @naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies. #LCSM #LungNETs #SCLC @thelancet.bsky.social www.thelancet.com/journals/lan...
THIS! Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer. Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏 #LCSM #SuppOnc bit.ly/4jiKwUz
COCOON study meets primary endpoint demonstrating statistically significant and clinically meaningful reduction in dermatologic reactions with easy-to-use prophylactic regimen for patients with EGFR-m...
bit.ly
Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si #LCSM #EndStigmaNow
Helping Health Professionals Reduce Lung Cancer Stigma
Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.
bit.ly
LUNGevity's RFA Day was Jan 13. Our newest mechanism is my baby. We are excited to offer bridge funding to mid-career investigators working in the #lungcancer space. We support workforce development AND retention to ensure a continuous pipeline of leaders to transform the field and improve outcomes.
LUNGevity Foundation@lungevity.bsky.social · 2y agoLUNGevity is pleased to announce the Mid-Career "Bridge to Breathe" Award. Mid-career investigators are often burdened by increasing administrative demands that jeopardize their ability to conduct cutting-edge research. Learn more and apply: lungevity.org/RFAs #RFADAY #transforminglungcancer #lcsm
Very interesting given my work in the #lungcancer and #cancer #cachexia space. Are patients with RET+ NSCLC on TKIs protected against cachexia and could RET drugs protect patients with other oncogene driven NSCLC (ex EGFR) where weight loss often occurs? #LCSM www.sciencedirect.com/science/arti...
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model
Anorexia is a major cause of cancer cachexia and is induced by growth differentiation factor-15 (GDF15), which activates the rearranged during transfe…
sciencedirect.com
